Larry A Allen

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. pmc Risk factors for adverse outcomes by left ventricular ejection fraction in a contemporary heart failure population
    Larry A Allen
    Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA
    Circ Heart Fail 6:635-46. 2013
  2. pmc The inpatient experience and predictors of length of stay for patients hospitalized with systolic heart failure: comparison by commercial, Medicaid, and Medicare payer type
    Larry A Allen
    Section of Advanced Heart Failure and Transplantation, University of Colorado Anschutz Medical Campus, Aurora, USA
    J Med Econ 16:43-54. 2013
  3. pmc End points for comparative effectiveness research in heart failure
    Larry A Allen
    Division of Cardiology, University of Colorado School of Medicine, Anschutz Medical Center, Aurora, CO 80045, USA
    Heart Fail Clin 9:15-28. 2013
  4. pmc Patterns of beta-blocker intensification in ambulatory heart failure patients and short-term association with hospitalization
    Larry A Allen
    Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
    BMC Cardiovasc Disord 12:43. 2012
  5. doi request reprint End-point selection for acute heart failure trials
    Larry A Allen
    Colorado Cardiovascular Outcomes Research Consortium and the Section of Advanced Heart Failure, Division of Cardiology, Department of Medicine, University of Colorado Denver, Anschutz Medical Campus, 12631 East 17th Avenue, Aurora, CO 80045, USA
    Heart Fail Clin 7:481-95. 2011
  6. pmc Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life
    Larry A Allen
    Colorado Cardiovascular Outcomes Research Group, University of Colorado Denver, Aurora, CO 80045, USA
    Circ Cardiovasc Qual Outcomes 4:389-98. 2011
  7. doi request reprint Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure
    Larry A Allen
    Colorado Cardiovascular Outcomes Research Consortium, University of Colorado Denver, Aurora, USA
    Circ Heart Fail 4:293-300. 2011
  8. doi request reprint Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure
    Larry A Allen
    Colorado Cardiovascular Outcomes Research Group, University of Colorado Denver, Aurora, CO, USA
    Am J Cardiol 105:1794-7. 2010
  9. doi request reprint Use of multiple biomarkers in heart failure
    Larry A Allen
    Division of Cardiology, Colorado Cardiovascular Outcomes Research Consortium and Section of Heart Failure and Cardiac Transplantation, University of Colorado Denver, Aurora, CO 80045, USA
    Curr Cardiol Rep 12:230-6. 2010
  10. doi request reprint Multi-marker strategies in heart failure: clinical and statistical approaches
    Larry A Allen
    The Division of Cardiology, University of Colorado Denver, Aurora, CO 80045, USA
    Heart Fail Rev 15:343-9. 2010

Detail Information

Publications35

  1. pmc Risk factors for adverse outcomes by left ventricular ejection fraction in a contemporary heart failure population
    Larry A Allen
    Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA
    Circ Heart Fail 6:635-46. 2013
    ..The relative importance of common predictor variables for important clinical outcomes across strata of LVEF is relatively unknown...
  2. pmc The inpatient experience and predictors of length of stay for patients hospitalized with systolic heart failure: comparison by commercial, Medicaid, and Medicare payer type
    Larry A Allen
    Section of Advanced Heart Failure and Transplantation, University of Colorado Anschutz Medical Campus, Aurora, USA
    J Med Econ 16:43-54. 2013
    ..While length of stay (LOS) is a primary determinant of resource use and post-discharge events, few models exist for estimating LOS...
  3. pmc End points for comparative effectiveness research in heart failure
    Larry A Allen
    Division of Cardiology, University of Colorado School of Medicine, Anschutz Medical Center, Aurora, CO 80045, USA
    Heart Fail Clin 9:15-28. 2013
    ..This strategy almost certainly requires increased reliance on prospective studies with proactive end-point capture, preferably in the setting of randomized allocation of the interventions being compared...
  4. pmc Patterns of beta-blocker intensification in ambulatory heart failure patients and short-term association with hospitalization
    Larry A Allen
    Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
    BMC Cardiovasc Disord 12:43. 2012
    ..However, patterns and safety of β-blocker intensification in routine practice are poorly described...
  5. doi request reprint End-point selection for acute heart failure trials
    Larry A Allen
    Colorado Cardiovascular Outcomes Research Consortium and the Section of Advanced Heart Failure, Division of Cardiology, Department of Medicine, University of Colorado Denver, Anschutz Medical Campus, 12631 East 17th Avenue, Aurora, CO 80045, USA
    Heart Fail Clin 7:481-95. 2011
    ....
  6. pmc Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life
    Larry A Allen
    Colorado Cardiovascular Outcomes Research Group, University of Colorado Denver, Aurora, CO 80045, USA
    Circ Cardiovasc Qual Outcomes 4:389-98. 2011
    ..Patients are concerned with both their quantity and quality of life (QoL). To facilitate the recognition of patients at high risk for unfavorable future QoL or death, we created a simple prognostic tool to estimate this combined outcome...
  7. doi request reprint Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure
    Larry A Allen
    Colorado Cardiovascular Outcomes Research Consortium, University of Colorado Denver, Aurora, USA
    Circ Heart Fail 4:293-300. 2011
    ..Heart failure (HF) is the leading cause of hospitalization among older Americans. Subsequent discharge to skilled nursing facilities (SNF) is not well described...
  8. doi request reprint Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure
    Larry A Allen
    Colorado Cardiovascular Outcomes Research Group, University of Colorado Denver, Aurora, CO, USA
    Am J Cardiol 105:1794-7. 2010
    ..Given the high prevalence of heart failure hospitalization and the disparate results of small studies regarding optimal dosing of loop diuretics to treat these patients, larger multicenter blinded studies are needed...
  9. doi request reprint Use of multiple biomarkers in heart failure
    Larry A Allen
    Division of Cardiology, Colorado Cardiovascular Outcomes Research Consortium and Section of Heart Failure and Cardiac Transplantation, University of Colorado Denver, Aurora, CO 80045, USA
    Curr Cardiol Rep 12:230-6. 2010
    ..Here we conceptually define multiple biomarker strategies, provide examples of emerging biomarker panels used in the care of patients with heart failure, and address key statistical and clinical issues for this rapidly evolving field...
  10. doi request reprint Multi-marker strategies in heart failure: clinical and statistical approaches
    Larry A Allen
    The Division of Cardiology, University of Colorado Denver, Aurora, CO 80045, USA
    Heart Fail Rev 15:343-9. 2010
    ..Here, we define multi-marker strategies, summarize recent examples of biomarker combinations in heart failure, address key statistical and clinical issues, and discuss future directions for this rapidly evolving field...
  11. doi request reprint End points for clinical trials in acute heart failure syndromes
    Larry A Allen
    Division of Cardiology, Department of Medicine, University of Colorado Denver, Aurora, CO 80045, USA
    J Am Coll Cardiol 53:2248-58. 2009
    ....
  12. doi request reprint Relationship between anemia and health care costs in heart failure
    Larry A Allen
    Division of Cardiology, University of Colorado Denver, Aurora, Colorado 80045, USA
    J Card Fail 15:843-9. 2009
    ..Anemia is associated with higher morbidity and mortality in patients with heart failure (HF), but its implications for heath care costs are not well described...
  13. doi request reprint Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device
    Amrut V Ambardekar
    University of Colorado Denver, Aurora, CO 80045, USA
    J Heart Lung Transplant 29:771-6. 2010
    ..However, the rate of implantable cardioverter-defibrillator (ICD) shocks and the effect of these shocks on outcomes in patients with LVADs remain unknown...
  14. pmc Rates and predictors of 30-day readmission among commercially insured and Medicaid-enrolled patients hospitalized with systolic heart failure
    Larry A Allen
    Section of Advanced Heart Failure and Transplantation, University of Colorado School of Medicine, Aurora, CO, USA
    Circ Heart Fail 5:672-9. 2012
    ....
  15. doi request reprint Patient-identified factors related to heart failure readmissions
    Jessica H Retrum
    School of Public Affairs, Department of Health and Behavioral Sciences, University of Colorado Denver, CO, USA
    Circ Cardiovasc Qual Outcomes 6:171-7. 2013
    ..Although readmission after hospitalization for heart failure has received increasing attention, little is known about its root causes. Prior investigations have relied on administrative databases, chart review, and single-question surveys...
  16. pmc Practice-level variation in use of recommended medications among outpatients with heart failure: Insights from the NCDR PINNACLE program
    Pamela N Peterson
    Department of Medicine, Denver Health Medical Center, Denver, CO
    Circ Heart Fail 6:1132-8. 2013
    ....
  17. doi request reprint Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure
    Larry A Allen
    Division of Cardiology, University of Colorado Denver, Aurora, CO, USA
    J Card Fail 16:230-8. 2010
    ..Our study sought to validate the prognostic value of RDW in heart failure and to explore the potential mechanisms underlying this association...
  18. doi request reprint Guideline concordance of testing for hyperkalemia and kidney dysfunction during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure
    Larry A Allen
    Colorado Cardiovascular Outcomes Research Consortium, Denver
    Circ Heart Fail 7:43-50. 2014
    ..Guidelines recommend measurement of serum potassium (K) and creatinine (Cr) before and serially after MRA initiation, but the extent to which this occurs is unknown...
  19. ncbi request reprint Comparison of long-term mortality across the spectrum of acute coronary syndromes
    Larry A Allen
    Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC, USA
    Am Heart J 151:1065-71. 2006
    ..Data are sparse regarding comparative long-term mortality across the spectrum of patients presenting with acute coronary syndrome (ACS)...
  20. pmc Giving voice to patients' and family caregivers' needs in chronic heart failure: implications for palliative care programs
    David B Bekelman
    Research and Genetics Sections, Department of Veterans Affairs Medical Center, Denver, Colorado, USA
    J Palliat Med 14:1317-24. 2011
    ....
  21. doi request reprint Health literacy and outcomes among patients with heart failure
    Pamela N Peterson
    Division of Cardiology, Denver Health Medical Center, Mail Code 0960, 777 Bannock St, Denver, CO 80204, USA
    JAMA 305:1695-701. 2011
    ..Little is known about the effects of low health literacy among patients with heart failure, a condition that requires self-management and frequent interactions with the health care system...
  22. pmc Management of acute decompensated heart failure
    Larry A Allen
    Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    CMAJ 176:797-805. 2007
    ..Multiple novel therapies are being developed, but previous treatment failures indicate that progress in the management of acute decompensated heart failure is likely to be slow...
  23. pmc Effects of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with left ventricular systolic dysfunction: a meta-analysis of randomized controlled trials
    Srinivas R Bapoje
    Department of Medicine, Denver Health and Hospital Authority, Denver, CO, USA
    Circ Heart Fail 6:166-73. 2013
    ..Mineralocorticoid receptor antagonists (MRAs) may attenuate this risk. The objective of this meta-analysis was to assess the impact of MRAs on SCD in patients with left ventricular systolic dysfunction...
  24. pmc Acculturation and outcomes among patients with heart failure
    Pamela N Peterson
    Denver Health Medical Center, Denver, CO, USA
    Circ Heart Fail 5:160-6. 2012
    ..In particular, those who are foreign-born and who do not speak English as their primary language may have greater challenges interacting with the health care system and thus be at greater risk for adverse outcomes...
  25. doi request reprint Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of measures of disease severity in acut
    Larry A Allen
    Division of Cardiology, University of Colorado Denver, Aurora, CO 80045, USA
    J Card Fail 14:777-84. 2008
    ..The natural evolution of signs and symptoms during acute heart failure (AHF) is poorly characterized...
  26. doi request reprint Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from get with the guidelines
    Larry A Allen
    Division of Cardiology and the Colorado Cardiovascular Outcomes Research Consortium, University of Colorado School of Medicine, Aurora
    Circ Heart Fail 7:251-60. 2014
    ..12) Conclusions- Use of intravenous inotropic agents during hospitalization for heart failure varies significantly among US hospitals even after accounting for patient and hospital factors. ..
  27. doi request reprint Impact of medication nonadherence on hospitalizations and mortality in heart failure
    Ashley A Fitzgerald
    Division of Cardiology, Denver VA Medical Center, Denver, Colorado, USA
    J Card Fail 17:664-9. 2011
    ..Limited literature exists on the association between medication adherence and outcomes among patients with heart failure...
  28. pmc Aging of the United States population: impact on heart failure
    Rebecca Vigen
    Division of Cardiology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Curr Heart Fail Rep 9:369-74. 2012
    ....
  29. doi request reprint Outpatient palliative care for chronic heart failure: a case series
    David B Bekelman
    Department of Veterans Affairs Medical Center, Denver, CO 80220, USA
    J Palliat Med 14:815-21. 2011
    ..This article describes the patients seen and the issues addressed in an outpatient palliative care program for patients with HF...
  30. pmc Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
    Larry A Allen
    Division of Cardiology, University of Colorado Denver, Aurora, CO, USA
    Eur J Heart Fail 11:170-7. 2009
    ..The prevalence and importance of liver function test (LFT) abnormalities in a large contemporary cohort of heart failure patients have not been systematically evaluated...
  31. pmc Palliative care and hospice in advanced heart failure
    Lisa Lemond
    Division of Cardiology, Department of Medicine, University of Colorado Denver, Anschutz Medical Center, Aurora, USA
    Prog Cardiovasc Dis 54:168-78. 2011
    ....
  32. pmc The evolving landscape of quality measurement for heart failure
    Ashley A Fitzgerald
    Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, USA
    Ann N Y Acad Sci 1254:131-9. 2012
    ....
  33. doi request reprint Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads
    Amrut V Ambardekar
    Division of Cardiology and Cardiothoracic Surgery, University of Colorado Denver, Aurora, CO 80045, USA
    J Card Fail 16:327-31. 2010
    ..We investigated whether the implantation of a LVAD affects ICD function...
  34. ncbi request reprint Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non-ST-elevation myocardial infarction
    Larry A Allen
    Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Am J Cardiol 93:1218-22. 2004
    ..In firmly establishing the benefit of consensus guidelines, the foundation is set for efforts to improve practitioner compliance with these standards...
  35. pmc Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis
    Jennifer L Dorosz
    Division of Cardiology, School of Medicine, University of Colorado Denver, Aurora, Colorado 80045, USA
    J Am Coll Cardiol 59:1799-808. 2012
    ..The primary aim of this systematic review is to objectively evaluate the test performance characteristics of three-dimensional echocardiography (3DE) in measuring left ventricular (LV) volumes and ejection fraction (EF)...